Steve McAdoo - Spineguard President
| ALSGD Stock | EUR 0.21 0.01 4.55% |
President
Mr. Steve McAdoo serves as Member of the Management Board and General Manager USA at SpineGuard S.A.. He joined company in January 2016 as VP Business Development. He has over 27 years of global marketing, sales management and business development experience in the medical device industry, including spine, general orthopedics, trauma, cardiovascular and urology. Over the course of his career, he has held roles in large corporations such as Medtronic, Smith Nephew, and Biomet as well as in startup companies like Danek Medical, Cerapedics, and SURx. since 2017.
| Tenure | 7 years |
| Phone | 33 1 45 18 45 19 |
| Web | https://www.spineguard.com |
Spineguard Management Efficiency
The company has return on total asset (ROA) of (0.082) % which means that it has lost $0.082 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4335) %, meaning that it generated substantial loss on money invested by shareholders. Spineguard's management efficiency ratios could be used to measure how well Spineguard manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 4 records | PRESIDENT Age | ||
| Eric Bantegnie | Kalray SA | N/A | |
| Stephane Cordova | Kalray SA | N/A | |
| Loic Hamon | Kalray SA | N/A | |
| Randy Skelley | Kalray SA | N/A | |
Management Performance
| Return On Equity | -0.43 | |||
| Return On Asset | -0.082 |
Spineguard Leadership Team
Elected by the shareholders, the Spineguard's board of directors comprises two types of representatives: Spineguard inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Spineguard. The board's role is to monitor Spineguard's management team and ensure that shareholders' interests are well served. Spineguard's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Spineguard's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pierreme, Chairman CoFounder | ||
| Manuel Lanfossi, CFO, Member of the Management Board, IR Contact Officer | ||
| Maurice Bourlion, CoInventor Director | ||
| Patricia Lempereur, Director of Marketing & Training, International, Member of the Management Board | ||
| Steve McAdoo, Vice President - Business Development, Member of the Management Board | ||
| Stphane Bette, Deputy CoFounder |
Spineguard Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Spineguard a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.43 | |||
| Return On Asset | -0.082 | |||
| Profit Margin | (0.44) % | |||
| Operating Margin | (0.33) % | |||
| Current Valuation | 18.77 M | |||
| Shares Outstanding | 31.71 M | |||
| Shares Owned By Institutions | 1.27 % | |||
| Price To Earning | (4.81) X | |||
| Price To Book | 3.68 X | |||
| Price To Sales | 4.11 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Spineguard Stock Analysis
When running Spineguard's price analysis, check to measure Spineguard's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spineguard is operating at the current time. Most of Spineguard's value examination focuses on studying past and present price action to predict the probability of Spineguard's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spineguard's price. Additionally, you may evaluate how the addition of Spineguard to your portfolios can decrease your overall portfolio volatility.